Skip to NavigationSkip to content

FDA grants approval for first generic version of Viagra

Published on 10/03/16 at 04:24pm

The US Food and Drug Administration (FDA) has granted approval to the first generic version of Pfizer’s blockbuster erectile dysfunction drug, Viagra (sildenafil citrate).

Israeli-based Teva Pharmaceuticals has received the approval, but have also agreed a deal with Pfizer to delay bringing the generic to market until December 2017. Reuters reported a similar deal struck between Pfizer and Mylan, with the latter’s generic still subject to FDA approval.

Teva has gained approval for the drug at 25mg, 50mg and 100mg doses. It previously launched its Viagra generic in the EU in 2013.

Teva will pay royalties through to the expiration of the Viagra patent in the US in April 2020.

Sean Murray

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches